Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group (Q44227096)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q60557915)
(P304) 431-437
(P433) 4
(P478) 20
(P577) Friday, November 1, 2002
(P921) (Q179991)
(Q42824440)
(Q16)
(P1433) (Q2312231)
(P1476) "Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group" (language: en)
(P2093) Ian Quirt
Audley Bodurth
Reinhard Lohmann
James Rusthoven
Karl Belanger
Vincent Young
Nancy Wainman
William Stewar
Elizabeth Eisenhauer
(P2860) (Q72959323)
(Q38156641)
(Q40496210)
(Q33496118)
(Q41719856)
(Q70505780)
(Q60043767)
(Q41072619)
(Q35976755)
other details
description scientific article

External Links